FirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and access will strengthen the payer position in demanding discounts in return for guaranteed patient access. Up-to-the-minute and based on the most current research and expert interviews, Trends and Innovations in Drug Pricing is an open window to the future of drug pricing.
Worldwide, the trend towards payers determining price has been firmly entrenched for years. Yet in the US, more aggressive approaches to pricing through exclusive deals that swap discounts for patient access are only now gaining traction.
As arrangements like that which saw Gilead Sciences granted exclusive coverage by CVS Health for the premium priced hepatitis C drugs Harvoni (ledipasvir/sofosbuvir) and Sovaldi (sofosbuvir) increasingly become the norm, the pricing landscape is likely to undergo significant change. And as payers focus is on containing costs and ensuring value for money, what is the takeaway message for pharma?
Get Answers to Important Questions
About FirstWord Reports
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
Learn more at www.firstwordgroup.com.
Table of Contents
for Trends and Innovations in Drug Pricing [Published by FirstWord Pharma]
2.Research Objective and Methodology
3.Key questions answered in the report
4.1.Payers tighten their grip
4.2.Case study 1: How US physicians kicked back against Zaltrap
5.The US still shapes global pricing
5.1.Case study 2: the Sovaldi price conundrum
6.Consolidating price controls in Europe
6.1.The UK tries to be transparent
6.2.The UK’s new PPRS scheme
6.4.Germany’s AMNOG procedure
6.5.Other European price controls
6.6.The impact of recession
6.7.Overview of pricing measures in Europe 2012/2013
6.8.Where to launch in Europe
6.9.The importance of sequencing
6.10.Impact on sequencing
7.A new emphasis on affordability
7.1.Case study 3: Soliris - Expensive but worth it
8.From list to net prices
8.1.Risk-sharing and reference pricing
8.2.Endpoints are not the whole outcome
8.4.Does risk-sharing work?
8.5.Think about it early
8.6.Case Study 4 : Pay if you clear
8.7.Will risk-sharing get more complicated?
8.8.Problems with risk-sharing
8.9.Real-world data are the tipping point
8.10.How confidential is confidential?
8.12.The impact of HTA networks
9.Value for money in pricing
10.What are we pricing for?
10.1.Shift from primary to specialist care
10.2.Translating cost into price
10.3.A genuine cure
10.4.Predictability in budget impact
10.5.Paying for the benefit now
10.6.Case study 5: Clearing out the Cancer Drugs Fund
10.7.Co-payments and affordability
10.8.Differential pricing and leakage
10.9.Prices and affordability
11.New problems, new solutions
12.Pricing by indication
13.The Future-where pricing is going now
|Title||Date Published||Price from||More Details|
|Trends and Innovations in Companion Diagnostics|
IntroductionAre companion diagnostics becoming a “must have” for market access? Companion Diagnostic...
|01 Apr 2016 by FirstWord Pharma||USD $695||More Info|
|Drug Delivery - Innovations, trends, and their impact on pharma|
IntroductionWhy you need Drug Delivery - Innovations, trends, and their impact on pharmaRevolutionar...
|01 Nov 2015 by FirstWord Pharma||USD $2,195||More Info|
|Trends and Innovations in Key Account Management|
IntroductionYour customers need and demand more from you today. Key Account Management (KAM) is the ...
|01 Jul 2015 by FirstWord Pharma||USD $695||More Info|
|Physician Views: Assessing new competitive trends in the oral anticoagulant market|
ScopeThe new class of oral anticoagulants – comprising the Factor Xa inhibitors Xarelto (Bayer/Johns...
|01 Jun 2015 by FirstWord Pharma||USD $695||More Info|
|Trends & Innovations Sales Force Effectiveness|
IntroductionWhat makes an ideal modern pharma sales representative and what skills, knowledge, tools...
|01 Apr 2015 by FirstWord Pharma||USD $695||More Info|
|Trends and Innovations in Patient Adherence|
IntroductionTaking the right dose of the right medicine at the right time is key to improving health...
|01 Mar 2015 by FirstWord Pharma||USD $695||More Info|
|Trends and Innovations in Lifecycle Management|
IntroductionTrends and Innovations in Lifecycle Management (LCM) presents business-critical insights...
|01 Feb 2015 by FirstWord Pharma||USD $695||More Info|
|Trends in Measuring and Rewarding KAM Team Performance|
IntroductionKey account managers (KAMs) are the new face of pharma sales. Whether meeting with hospi...
|24 Nov 2014 by FirstWord Pharma||USD $695||More Info|
|Therapy Trends: Alzheimer's Disease - Breaking new ground in disease modification|
IntroductionIn 2012, the Alzheimer’s disease (AD) market was dealt a huge blow following negative re...
|01 Dec 2012 by FirstWord Pharma||USD $7,900||More Info|
|Pricing and Reimbursement Trends in the US: Impact of Comparative Effectiveness Research and Cost-Effectiveness Analysis|
IntroductionPublic healthcare costs are rising. Governments need to get them under control. In Europ...
|01 Jan 2012 by FirstWord Pharma||USD $695||More Info|
This report is published by FirstWord Pharma
Download Free Report Summary PDF
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.